Clinical Trials Browser

Phase NA × Cladribine × 90 days × Clear all

NCT05657652 2025-12-29

CAV Regimen for R/R Ph- B-ALL

Phase NA Recruiting

LymphoidOther hematologic neoplasm

Recurrence, Precursor Cell Lymphoblastic Leukemia-Lymphoma